Delivery Order SPE2DB20D1100-SPE2DB26FE0SK
- Not listed
- The Defense Logistics Agency (DLA) awarded a $2,624.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cryselle-28 tablets (28-count packages) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded contract, with no set-aside designation, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Cryselle-28 tablets, a birth control medication, with a ceiling value of $5,708.05. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,556.30 firm fixed-price contract is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a performance period ending on May 16, 2025. The contract is not set aside and was awarded on May 15, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,702.12, is for the delivery of CRYSELLE-28 TABLET 28S medical supplies. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price contract type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
- This is a $2,183.59 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CRYSELLE-28 TABLET 28S, a medical product, with a period of performance through April 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,153.66, is for the delivery of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a performance period through March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency awarded a $1,173.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562355585 CRYSELLE-28 TABLET 28S. The delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from September 29, 2023 through October 2, 2023. As the prime contractor, Amerisourcebergen will be...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $99,722.94 to AmerisourceBergen Drug Corp on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract calls for pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,022.44 to AmerisourceBergen Drug Corp on September 18, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $35,097.32 to AmerisourceBergen Drug Corp on September 22, 2025, with completion expected by September 23, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The vendor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location and supply...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB26FE0SKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,782.19 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on October 17, 2025, with completion targeted for October 20, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger SPE2DX indefinite delivery contract with DLA valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's federal contract portfolio demonstrates extensive capabilities in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded, non-set-aside contracts reflects its established capability to meet federal procurement requirements within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 10/17/25 |